New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For DELL;ADNC;MRK;TSN;CTRP;GDOT;VVUS;NFLX;MCK;MAT;LTM;ALKS;ELN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>
September 29, 2014
16:54 EDTNFLXNetflix in talks on feature film with Weinstein Co., Bloomberg says
Subscribe for More Information
11:40 EDTNFLXOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTMCKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTMATOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:48 EDTALKSAlkermes management to meet with Leerink
Meetings to be held in Canada October 6-7 hosted by Leerink.
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
09:22 EDTMATMattel downgraded to Neutral from Buy at MKM Partners
Subscribe for More Information
07:26 EDTMRKInforma Business Information to hold a conference
Subscribe for More Information
07:25 EDTDELLOracle to hold a conference
Open World 2014 to be held in San Francisco on September 28-October 2.
06:59 EDTMATMattel downgraded to Neutral from Buy at MKM Partners
05:44 EDTMRKMerck announces early data from investigational use of KEYTRUDA
Merck announced the first presentation of data on the investigational use of KEYTRUDA, the company’s anti-PD-1 therapy, in PD-L1 positive, advanced urothelial cancer. The early findings presented showed a confirmed overall response rate of 24% with KEYTRUDA as monotherapy, as measured by RECIST v1.1, central review including a complete response rate of 10%. At the time of analysis, response durations ranged from 16+ to 40+ weeks with six of the seven responders continuing on therapy. In the ongoing study, 64% of patients screened had tumors that were determined to be positive for PD-L1 expression.
05:30 EDTMCKMcKesson initiated with an Overweight at Barclays
Target $223.
September 28, 2014
19:38 EDTCTRPCtrip.com to purchase certain premises in Sky SOHO
Subscribe for More Information
12:53 EDTMRKMerck announces first presentation of data on investigational use of KEYTRUDA
Subscribe for More Information
September 26, 2014
16:55 EDTMATMarket ends week lower after inversion crackdown, mixed data
Subscribe for More Information
09:37 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:31 EDTMRKLigand, Merck receive approval for NOXAFIL
Subscribe for More Information
September 25, 2014
17:50 EDTNFLXCompanies receive U.S. information requests on Comcast-TWC deal, Bloomberg says
Subscribe for More Information
16:00 EDTNFLXOptions Update; September 25, 2014
iPath S&P 500 VIX Short-Term Futures up 2.09 to 30.38. Option volume leaders: AAPL TSLA NFLX BAC TWTR AMZN BP PBR GILD DOW according to Track Data.
15:05 EDTCTRPData suggest Ctrip.com may beat Q3 revenue guidance, says Piper Jaffray
Piper Jaffray said its analysis of China hotel and air travel data in the first two months of Q3 suggests Ctrip.com should at least hit the high end of its 30%-35% revenue growth forecast and may beat it, but by a lower amount than the company has previously beat in prior quarters. The firm maintains its Neutral rating on Ctrip, citing the volatility in China travel fundamentals.
<< 1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use